What is Shanghai Fosun Pharmaceutical (Group) Co Price-to-Operating-Cash-Flow?
As of today (2025-06-05), Shanghai Fosun Pharmaceutical (Group) Co's share price is ¥25.15.
Shanghai Fosun Pharmaceutical (Group) Co's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Mar. 2025 was ¥1.74. Hence, Shanghai Fosun Pharmaceutical (Group) Co's Price-to-Operating-Cash-Flow Ratio for today is 14.47.
The historical rank and industry rank for Shanghai Fosun Pharmaceutical (Group) Co's Price-to-Operating-Cash-Flow or its related term are showing as below:
SHSE:600196'
s Price-to-Operating-Cash-Flow Range Over the Past 10 Years
Min: 13.46 Med: 26.73 Max: 74.1
Current: 14.46
During the past 13 years, Shanghai Fosun Pharmaceutical (Group) Co's highest Price-to-Operating-Cash-Flow Ratio was 74.10. The lowest was 13.46. And the median was 26.73.
Shanghai Fosun Pharmaceutical (Group) Co's Cash Flow from Operations per share for the
three
months ended in Mar. 2025 was ¥0.40.
Its Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Mar. 2025 was ¥1.74.
During the past 12 months, the average Operating Cash Flow per Share Growth Rate of Shanghai Fosun Pharmaceutical (Group) Co was 35.50% per year.
During the past 3 years, the average Operating Cash Flow per Share Growth Rate was 2.90% per year.
During the past 5 years, the average Operating Cash Flow per Share Growth Rate was 6.50% per year.
During the past 10 years, the average Operating Cash Flow per Share Growth Rate was 10.10% per year.
During the past 13 years, Shanghai Fosun Pharmaceutical (Group) Co's highest 3-Year average Operating Cash Flow per Share Growth Rate was 61.40% per year. The lowest was -19.90% per year. And the median was 11.80% per year.
Shanghai Fosun Pharmaceutical (Group) Co Price-to-Operating-Cash-Flow Historical Data
The historical data trend for Shanghai Fosun Pharmaceutical (Group) Co's Price-to-Operating-Cash-Flow can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Shanghai Fosun Pharmaceutical (Group) Co Price-to-Operating-Cash-Flow Chart
|
Shanghai Fosun Pharmaceutical (Group) Co Annual Data
|
|
Trend |
Dec15 |
Dec16 |
Dec17 |
Dec18 |
Dec19 |
Dec20 |
Dec21 |
Dec22 |
Dec23 |
Dec24 |
| Price-to-Operating-Cash-Flow |
|
Get a 7-Day Free Trial
|
|
|
53.61 |
31.76 |
21.79 |
19.66 |
14.78 |
|
Shanghai Fosun Pharmaceutical (Group) Co Quarterly Data
|
|
Jun20 |
Sep20 |
Dec20 |
Mar21 |
Jun21 |
Sep21 |
Dec21 |
Mar22 |
Jun22 |
Sep22 |
Dec22 |
Mar23 |
Jun23 |
Sep23 |
Dec23 |
Mar24 |
Jun24 |
Sep24 |
Dec24 |
Mar25 |
| Price-to-Operating-Cash-Flow |
Get a 7-Day Free Trial
|
|
|
|
|
|
|
|
|
|
|
|
|
17.98 |
17.06 |
18.98 |
14.78 |
14.29 |
Competitive Comparison of Shanghai Fosun Pharmaceutical (Group) Co's Price-to-Operating-Cash-Flow
For the Drug Manufacturers - Specialty & Generic subindustry, Shanghai Fosun Pharmaceutical (Group) Co's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Shanghai Fosun Pharmaceutical (Group) Co's Price-to-Operating-Cash-Flow Distribution in the Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Shanghai Fosun Pharmaceutical (Group) Co's Price-to-Operating-Cash-Flow distribution charts can be found below:
* The bar in red indicates where Shanghai Fosun Pharmaceutical (Group) Co's Price-to-Operating-Cash-Flow falls into.
Shanghai Fosun Pharmaceutical (Group) Co Price-to-Operating-Cash-Flow Calculation
Shanghai Fosun Pharmaceutical (Group) Co's Price-to-Operating-Cash-Flow ratio for today is calculated as
| Price-to-Operating-Cash-Flow Ratio | = | Share Price | / | Cash Flow from Operations per share (TTM) |
| = | 25.15 | / | 1.738 |
| = | 14.47 |
Shanghai Fosun Pharmaceutical (Group) Co's Share Price of today is ¥25.15.
Shanghai Fosun Pharmaceutical (Group) Co's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥1.74.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Note: Cash Flow from Operations per share is calculated as Cash Flow from Operations divided by Shares Outstanding (Diluted Average).
It can also be calculated from the numbers for the whole company:
Shanghai Fosun Pharmaceutical (Group) Co Business Description
Traded in Other Exchanges
Address
No. 1289 Yishan Road, Building A, Fosun Technology Park, Shanghai, CHN, 200233
Shanghai Fosun Pharmaceutical (Group) Co Ltd is engaged in the development, manufacture, and sale of pharmaceutical products and medical equipment, the import and export of medical equipment, and the provision of related and other consulting services and investment management. Its business segments are Pharmaceutical manufacturing, Healthcare Services, Medical devices, and medical diagnosis. It generates the majority of its revenue from the Pharmaceutical manufacturing segment. The company considers mergers and acquisitions as a potential component of its operational growth for expanding its research, development, manufacturing, and marketing capabilities. Its geographic areas are the Chinese mainland, Regions outside the Chinese mainland, and other countries.
Executives
Shanghai Fosun Pharmaceutical (Group) Co Headlines
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
SHSE:600196 has been successfully added to your